MiR-210: A potential therapeutic target against radiation-induced enteropathy

Saad Hamama, Muhammad Zaeem Noman, Pascal Gervaz, Sylvie Delanian, Marie Catherine Vozenin*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)


A previously undescribed and robust miR210 overexpression is shown in intestinal samples obtained from patients with radiation enteropathy and fibrotic cultured cells. In addition, miR-210 overexpression is repressed by antifibrotic treatment combining pentoxifylline and α-tocopherol.

Original languageEnglish
Pages (from-to)219-221
Number of pages3
JournalRadiotherapy and Oncology
Issue number2
Publication statusPublished - May 2014
Externally publishedYes


  • Anti-fibrotic treatment
  • Pentoxifylline
  • Radiation enteropathy
  • Radiation-induced fibrosis
  • Trolox
  • microRNA miR-210


Dive into the research topics of 'MiR-210: A potential therapeutic target against radiation-induced enteropathy'. Together they form a unique fingerprint.

Cite this